Pacira BioSciences, Inc.PCRXNASDAQ
Loading
Cost of Revenue Over TimeStable
Percentile Rank79
3Y CAGR-6.3%
5Y CAGR+6.9%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
-6.3%/yr
vs +23.1%/yr prior
5Y CAGR
+6.9%/yr
Recent deceleration
Acceleration
-29.4pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
3 yr
Consecutive declineStable
PeriodValueYoY Change
TTM$164.07M-3.7%
2024$170.43M-7.7%
2023$184.67M-7.3%
2022$199.29M+42.1%
2021$140.25M+19.5%
2020$117.33M+9.9%
2019$106.71M+22.9%
2018$86.84M-1.2%
2017$87.92M-20.2%
2016$110.10M-